Literature DB >> 12719589

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells.

Jun Tang1, Gabriel M Gordon, Maike G Müller, Madhu Dahiya, Kimberly E Foreman.   

Abstract

Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) (also known as human herpesvirus 8) is a gamma-2 herpesvirus believed to be the etiologic agent responsible for KS. The pathogenesis of this potentially life-threatening neoplasm is complex and unclear, and it is currently unknown how KSHV causes KS. Id (named for inhibitor of DNA binding or inhibitor of differentiation) proteins were identified in 1990 and found to be naturally occurring dominant-negative inhibitors of basic helix-loop-helix transcription factors. Id-1, the most well-studied member of this family, has since been shown to play a key role in several biological systems including cellular differentiation, cell cycle regulation, and tumorigenesis. In this report, we demonstrate that Id-1 is expressed at high levels in KS tumor cells both in vitro and in vivo but is expressed at relatively modest levels in endothelial cells (ECs), the likely precursor of the KS tumor cell. Infection of precursor cells with KSHV may be responsible for this enhanced expression, as KSHV infection induced Id-1 27-fold in ECs under our experimental conditions. Furthermore, we demonstrate that the KSHV-encoded latency-associated nuclear antigen (LANA) protein appears to be involved. Expression of LANA in ECs resulted in Id-1 induction that was almost identical to the induction seen with KSHV-infected ECs. These results demonstrate the expression of Id-1 in KS tumor cells and indicate the KSHV LANA protein may be, at least in part, responsible. This may be an important mechanism by which KSHV allows KS tumor cells to escape normal cell cycle regulation and enhances their proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719589      PMCID: PMC154010          DOI: 10.1128/jvi.77.10.5975-5984.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer.

Authors:  M Schindl; G Oberhuber; A Obermair; S F Schoppmann; B Karner; P Birner
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

2.  Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions.

Authors:  K E Foreman; J Friborg; B Chandran; H Katano; T Sata; M Mercader; G J Nabel; B J Nickoloff
Journal:  J Dermatol Sci       Date:  2001-07       Impact factor: 4.563

3.  The protein Id: a negative regulator of helix-loop-helix DNA binding proteins.

Authors:  R Benezra; R L Davis; D Lockshon; D L Turner; H Weintraub
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

4.  Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.

Authors:  Lynn J Poole; Yanxing Yu; Peter S Kim; Qi-Zhi Zheng; Jonathan Pevsner; Gary S Hayward
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Posttranscriptional regulation of Id1 activity in cardiac muscle. Alternative splicing of novel Id1 transcript permits homodimerization.

Authors:  J P Springhorn; K Singh; R A Kelly; T W Smith
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

6.  DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  A C Garber; M A Shu; J Hu; R Renne
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells.

Authors:  Jun Tang; Gabriel M Gordon; Brian J Nickoloff; Kimberly E Foreman
Journal:  Lab Invest       Date:  2002-08       Impact factor: 5.662

8.  The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.

Authors:  A Iavarone; P Garg; A Lasorella; J Hsu; M A Israel
Journal:  Genes Dev       Date:  1994-06-01       Impact factor: 11.361

9.  C5a-induced expression of P-selectin in endothelial cells.

Authors:  K E Foreman; A A Vaporciyan; B K Bonish; M L Jones; K J Johnson; M M Glovsky; S M Eddy; P A Ward
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.

Authors:  M Djerbi; V Screpanti; A I Catrina; B Bogen; P Biberfeld; A Grandien
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

View more
  34 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype.

Authors:  Claudia Grossmann; Simona Podgrabinska; Mihaela Skobe; Don Ganem
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  Hong-Yi Pan; Yan-Jin Zhang; Xin-Ping Wang; Jian-Hong Deng; Fu-Chun Zhou; Shou-Jiang Gao
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 6.  Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.

Authors:  Soren Gantt; Corey Casper
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

7.  The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.

Authors:  Shijun Li; Min Tan; Franceline Juillard; Rajesh Ponnusamy; Bruno Correia; J Pedro Simas; Maria A Carrondo; Colin E McVey; Kenneth M Kaye
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

8.  Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.

Authors:  Hagar Tadmor; Melanie Greenway; Anuj Ahuja; Ola Orgil; Gangling Liao; Richard F Ambinder; S Diane Hayward; Meir Shamay
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

9.  Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Seung Min Yoo; Jian-Ping Xie; Philip J Browning; Shou-Jiang Gao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence.

Authors:  Brenna Kelley-Clarke; Erika De Leon-Vazquez; Katherine Slain; Andrew J Barbera; Kenneth M Kaye
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.